ATE73658T1 - Diaetzusatz zur verminderung der gefahr einer infektion. - Google Patents

Diaetzusatz zur verminderung der gefahr einer infektion.

Info

Publication number
ATE73658T1
ATE73658T1 AT85903749T AT85903749T ATE73658T1 AT E73658 T1 ATE73658 T1 AT E73658T1 AT 85903749 T AT85903749 T AT 85903749T AT 85903749 T AT85903749 T AT 85903749T AT E73658 T1 ATE73658 T1 AT E73658T1
Authority
AT
Austria
Prior art keywords
diet
infection
omega
rich
disclosed
Prior art date
Application number
AT85903749T
Other languages
English (en)
Inventor
Edward A Mascioli
George L Blackburn
Bruce R Bistrian
Vigen K Babayan
Original Assignee
Edward A Mascioli
George L Blackburn
Bruce R Bistrian
Babayan Vigan K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24528374&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE73658(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Edward A Mascioli, George L Blackburn, Bruce R Bistrian, Babayan Vigan K filed Critical Edward A Mascioli
Application granted granted Critical
Publication of ATE73658T1 publication Critical patent/ATE73658T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT85903749T 1984-07-12 1985-07-11 Diaetzusatz zur verminderung der gefahr einer infektion. ATE73658T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/630,732 US4752618A (en) 1984-07-12 1984-07-12 Method of minimizing efects of infection through diet
PCT/US1985/001332 WO1986000523A1 (en) 1984-07-12 1985-07-11 Dietary supplement and method of minimizing effects of infection through diet
EP85903749A EP0188573B1 (de) 1984-07-12 1985-07-11 Diätzusatz zur verminderung der gefahr einer infektion

Publications (1)

Publication Number Publication Date
ATE73658T1 true ATE73658T1 (de) 1992-04-15

Family

ID=24528374

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85903749T ATE73658T1 (de) 1984-07-12 1985-07-11 Diaetzusatz zur verminderung der gefahr einer infektion.

Country Status (7)

Country Link
US (2) US4752618A (de)
EP (1) EP0188573B1 (de)
JP (1) JPH0759508B2 (de)
AT (1) ATE73658T1 (de)
AU (2) AU604633B2 (de)
DE (1) DE3585681D1 (de)
WO (1) WO1986000523A1 (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225441A (en) * 1987-06-18 1993-07-06 Block Drug Company, Inc. Treatment of periodontal disease
US5116871A (en) * 1988-09-13 1992-05-26 Efamol Holdings Plc Fatty acid therapy and compositions for the treatment of myalgic encephalomyelitis
US4981844A (en) * 1988-10-04 1991-01-01 University Of Cincinnati Method to improve immune response and resistance to infection following surgery by diet composition
US5055446A (en) * 1988-10-21 1991-10-08 University Of Cincinnati Method to improve survival of patients during sepsis by diet composition
US5231085A (en) * 1988-10-31 1993-07-27 Sandoz Ltd. Compositions and methods for the enhancement of host defense mechanisms
US5576351A (en) * 1989-12-29 1996-11-19 Mcgaw, Inc. Use of arginine as an immunostimulator
US5407957A (en) * 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
US5089268A (en) * 1990-05-02 1992-02-18 Katz David P Egg phosphatide lipid emulsions altered for a specific therapeutic fatty acid composition
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
GB9026648D0 (en) * 1990-12-07 1991-01-23 Efamol Holdings Nutrition
ES2092539T3 (es) * 1991-01-10 1996-12-01 Transcend Therapeutics Inc Uso de derivados de la tiazolidina-4-carboxilato para el tratamiento de enfermedades pulmonares.
EP0568606B1 (de) * 1991-01-24 2001-04-18 Martek Corporation Mikrobielle öle und ihre verwendungen
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
SE9101642D0 (sv) * 1991-05-30 1991-05-30 Kabi Pharmacia Ab Phospholipids
EP0587787A4 (en) * 1991-06-07 1994-07-27 Martek Corp Brain lipid extracts and method for the production and use thereof
JPH05163160A (ja) * 1991-12-13 1993-06-29 Snow Brand Milk Prod Co Ltd 免疫低下に伴う感染症の予防及び治療用栄養剤
US5278149A (en) * 1992-01-17 1994-01-11 New England Deaconess Hospital Corporation Method of preparing total parenteral nutrition solutions
SE9200541D0 (sv) * 1992-02-24 1992-02-24 Kabi Pharmacia Ab New usee of omega-3-fatty acids
US5261586A (en) * 1992-03-26 1993-11-16 Chen Jen Fu Yarn feeding device with a guiding flange
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5260336A (en) * 1992-04-30 1993-11-09 New England Deaconess Hospital Corporation Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness
US5356873A (en) * 1992-11-05 1994-10-18 Clintec Nutrition Co. Method for providing nutritional requirements to patients having a chronic inflammation reaction
CA2151820C (en) * 1993-01-15 2000-11-28 Stephen Joseph Demichele Structured lipids
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
US5855949A (en) * 1994-01-10 1999-01-05 Mclean; Linsey Dietary system high in oil intake
US5484623A (en) * 1994-01-10 1996-01-16 Mclean; Linsey Dietary system high in oil intake for the treatment of obesity and for the lowering of saturated fats
AU1928295A (en) * 1994-02-25 1995-09-11 New England Deaconess Hospital Corporation Anti-inflammatory and infection protective effects of sesamin-based lignans
US5397778A (en) * 1994-02-25 1995-03-14 New England Deaconess Hospital Corporation Enteral formulations for treatment of inflammation and infection
GB9403935D0 (en) * 1994-03-01 1994-04-20 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5574065A (en) * 1994-04-21 1996-11-12 Clintec Nutrition Co. Method and composition for normalizing injury response
US6974796B1 (en) 1999-08-17 2005-12-13 Girsh Leonard S Therapeutic compositions for treatment of a damaged tissue
US20070231402A1 (en) * 1994-08-02 2007-10-04 Immunopath Profile, Inc. Therapeutic stem cell composition and stimulant, facilitator, accelerator, and synergizer thereof, growth factor, anti-inflammatory composition and uses thereof
GB9419345D0 (en) * 1994-09-26 1994-11-09 Sandoz Nutrition Ltd Organic compounds
PT843972E (pt) * 1996-11-20 2002-12-31 Nutricia Nv Composicao nutritiva que inclui gorduras para o tratamento do sindrome metabolico
US5993221A (en) * 1997-05-01 1999-11-30 Beth Israel Deaconess Medical Center, Inc. Dietary formulation comprising arachidonic acid and methods of use
US6194379B1 (en) 1998-05-01 2001-02-27 Abbott Laboratories Elemental enteral formula
KR100341109B1 (ko) * 1999-03-10 2002-06-20 이인수 인식력 및 기억력 증강용 식이 조성물
EP1634601A3 (de) * 1999-07-09 2008-02-13 Sun Farm Corporation Nahrungsergänzungsmittel, enthaltend Soja, Pilz und Mungobohne
US20090274660A1 (en) 1999-08-17 2009-11-05 Immunopath Profile, Inc. Pluripotent therapeutic compositions and uses thereof
US20070037777A1 (en) * 2005-08-12 2007-02-15 Immunopath Profile, Inc. Lipid-containing compositions and methods of using them
US7790678B1 (en) 1999-08-17 2010-09-07 Immunopath Profile, Inc. Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy and anti-cancer activity and methods of use
AU784123B2 (en) * 1999-10-13 2006-02-09 Marco A. Chacon Therapeutic intervention to mimic the effect of caloric restriction
BR0111313A (pt) * 2000-06-01 2003-06-03 United Feeds Inc Métodos para aumentar, o desempenho reprodutivo de uma porca, para aumentar o número de nascidos vivos para uma porca, para aumentar o número total de nascidos para uma porca, para diminuir o intervalo de desmame até estro para uma porca, para diminuir o intervalo de desmame até reacasalamento para uma porca, para aumentar a uniformidade do peso de nascido da prole de uma porca, para diminuir a perda por morte por pré-desmame da prole de uma porca, para aumentar a taxa de parto de uma porca, para aumentar a fertilidade de um porco e para aumentar o desempenho reprodutivo de uma população de procriação de porcos, e, composição de ração de suìno
JP2004527501A (ja) * 2001-03-05 2004-09-09 ピー． アーネスト，スティーヴン 経腸処方
US20050058671A1 (en) * 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders
US7988989B2 (en) * 2003-05-09 2011-08-02 Freedom Health, Llc Nutritional product for enhancing growth and/or strengthening the immune system of equine foals
US7824706B2 (en) 2003-05-09 2010-11-02 Freedom Health, Llc Dietary supplement and method for the treatment of digestive tract ulcers in equines
US7658964B2 (en) * 2003-05-09 2010-02-09 Freedom Health, Llc Dietary supplement and method for increasing the colostrum immunoglobulin levels in equine mares
US20060280776A1 (en) * 2003-09-02 2006-12-14 Masafumi Koide Diet food
EP1684739A4 (de) 2003-11-12 2006-12-06 Childrens Medical Center Behandlung und prävention von lebererkrankungen im zusammenhang mit parenteraler ernährung (pn)
US8652508B2 (en) * 2007-05-25 2014-02-18 Children's Medical Center Corporation Dietary formulations and methods for treatment of inflammation and other disorders
ES2748136T3 (es) 2007-10-15 2020-03-13 United Animal Health Inc Método para aumentar el rendimiento de las crías
EP2224911A4 (de) * 2007-11-30 2013-05-08 Jbs United Inc Verfahren und zusammensetzung zur behandlung von lungenhämorrhagie
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8241672B2 (en) * 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
US20110206741A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation DHA Triglyceride Emulsions
WO2011103512A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha free fatty acid emulsions
WO2011103510A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha ester emulsions
US20110223246A1 (en) * 2010-03-10 2011-09-15 Joar Opheim Docosahexaenoic acid bound in phospholipids and method of recovering same from a natural source
JP5710150B2 (ja) * 2010-04-08 2015-04-30 持田製薬株式会社 潜伏性感染疾患の再発抑制剤
PL3664628T3 (pl) 2017-08-10 2025-04-07 The Children's Medical Center Corporation Sposoby i kompozycje związane z emulsjami zawierającymi olej rybi i/albo kwasy tłuszczowe omega-3

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2977283A (en) * 1956-04-30 1961-03-28 Upjohn Co Therapeutic intravenous fat compositions
DE2533612A1 (de) * 1974-08-19 1976-03-04 Pharmacia Ab Parenteral verabreichbares oel und verfahren zu seiner herstellung
AU527784B2 (en) * 1978-05-26 1983-03-24 Bang, Hans Olaf Dr. Treatment of thromboembolic conditions withall-z)-5, 8, 11, 14, 17-eicosapentaenoic acid
JPS57169416A (en) * 1981-04-14 1982-10-19 Nippon Suisan Kaisha Ltd Health food
GB2098065A (en) * 1981-04-14 1982-11-17 Nippon Suisan Kaisha Ltd Antithrombotic compositions containing docosahexaenoic acid
ATE24266T1 (de) * 1982-04-16 1987-01-15 Nestle Sa Lipidhaltige zusammensetzung fuer die orale, enterale oder parenterale ernaehrung.
IL69782A (en) * 1982-09-22 1987-12-20 Sentrachem Ltd Compositions for preventing cancerous conditions comprising precursors of eicosanoid mixtures and a dietary supplement containing them
JPS59172416A (ja) * 1983-03-18 1984-09-29 Terumo Corp 脂肪輸液
JPH0615469B2 (ja) * 1984-05-09 1994-03-02 テルモ株式会社 脂肪輸液剤
US4678808A (en) * 1985-10-15 1987-07-07 Baxter Travenol Laboratories, Inc. Rapid acting intravenous emulsions of omega-3 fatty acid esters

Also Published As

Publication number Publication date
DE3585681D1 (de) 1992-04-23
US4752618A (en) 1988-06-21
WO1986000523A1 (en) 1986-01-30
AU4632685A (en) 1986-02-10
EP0188573B1 (de) 1992-03-18
EP0188573A4 (de) 1987-03-30
JPS61502816A (ja) 1986-12-04
US4820731A (en) 1989-04-11
AU628662B2 (en) 1992-09-17
EP0188573A1 (de) 1986-07-30
AU604633B2 (en) 1991-01-03
AU6375190A (en) 1991-05-09
JPH0759508B2 (ja) 1995-06-28

Similar Documents

Publication Publication Date Title
ATE73658T1 (de) Diaetzusatz zur verminderung der gefahr einer infektion.
TNSN86111A1 (fr) Procede de preparation d'hydroxyalkylxanthines tertiaires
ATE366521T1 (de) Verfahren zur verwendung von zusammensetzungen von konjugierter linolsäure die mit isomeren angereichert sind
DE3675796D1 (de) Verfahren zur herstellung von entschleimten pflanzlichen oelen und schleim mit hohem gehalt an phosphatidischer saeure.
IT8423086A1 (it) Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
IL84425A (en) (s) - (+) -ibuprofen-containing pharmaceutical compositions
NZ218500A (en) Refined fish oil concentrate containing fatty acid esters and their production
ATE81290T1 (de) Zusammensetzungen mit einem gehalt an mikroflora mit erhoehter adhaesion.
ES8705748A1 (es) Un procedimiento para la preparacion de una formula alimenticia baja en hidratos de carbono y alta en grasas.
FR2618332B1 (fr) Emulsion lipidique destinee a la nutrition parenterale ou enterale
EP0651611A4 (en) Modified fat blends.
ES2002384A6 (es) Un procedimiento para la preparacion de una base para supositorios
GB2182942B (en) Improvements in and relating to margarine and like fat compositions
ATE73996T1 (de) Verwendung lang- und mittelkettiger triglyzeride.
AU2072088A (en) Agent containing salicylic acid for treating lepidosis
DE3685275D1 (de) Herstellung von 5-fluor-2'-deoxyuridin estern zur intravenoesen verabreichung.
ATE86108T1 (de) Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.
JPS6422810A (en) Skin cosmetic
PT89654A (pt) Processo para a preparacao de composicoes que contem gorduras com um baixo conteudo de fosfatidos
BE901206A (fr) Emulsion pour transfusion.
ATE59779T1 (de) Verfahren zur regulierung der tierischen fortpflanzung.
EP0219839A3 (de) Derivat des Interleukin-2, seine Herstellung und Verwendung
GR3006760T3 (de)
GB2165153B (en) Hydrosoluble pharmaceutical compositions containing salts of (-)cis-1,2-epoxypropylphosphonic acid with aminoacids
SE8800101D0 (sv) Anvendning av essentiella fettsyror for framstellning av ett preparat for behandling av eksem

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked